Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial

S Møller-Bisgaard, K Hørslev-Petersen, B Ejbjerg, ML Hetland, R Christensen, LM Ørnbjerg, D Glinatsi, JM Møller, M Boesen, K Stengaard-Pedersen, OR Madsen, B Jensen, JA Villadsen, EM Hauge, P Bennett, O Hendricks, K Asmussen, M Kowalski, H Lindegaard, H Bliddal, NS Krogh, T Ellingsen, AH Nielsen, L Larsen, AG Jurik, HS Thomsen, M Østergaard

Open source

DOI: 10.1080/03009742.2021.1935312
Published: 2021-09-02
Container: Scandinavian Journal of Rheumatology
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/03009742.2021.1935312,
  title = {Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial},
  author = {S Møller-Bisgaard and K Hørslev-Petersen and B Ejbjerg and ML Hetland and R Christensen and LM Ørnbjerg and D Glinatsi and JM Møller and M Boesen and K Stengaard-Pedersen and OR Madsen and B Jensen and JA Villadsen and EM Hauge and P Bennett and O Hendricks and K Asmussen and M Kowalski and H Lindegaard and H Bliddal and NS Krogh and T Ellingsen and AH Nielsen and L Larsen and AG Jurik and HS Thomsen and M Østergaard},
  year = {2021},
  journal = {Scandinavian Journal of Rheumatology},
  doi = {10.1080/03009742.2021.1935312},
  url = {https://doi.org/10.1080/03009742.2021.1935312}
}

RIS

TY  - JOUR
TI  - Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial
AU  - S Møller-Bisgaard
AU  - K Hørslev-Petersen
AU  - B Ejbjerg
AU  - ML Hetland
AU  - R Christensen
AU  - LM Ørnbjerg
AU  - D Glinatsi
AU  - JM Møller
AU  - M Boesen
AU  - K Stengaard-Pedersen
AU  - OR Madsen
AU  - B Jensen
AU  - JA Villadsen
AU  - EM Hauge
AU  - P Bennett
AU  - O Hendricks
AU  - K Asmussen
AU  - M Kowalski
AU  - H Lindegaard
AU  - H Bliddal
AU  - NS Krogh
AU  - T Ellingsen
AU  - AH Nielsen
AU  - L Larsen
AU  - AG Jurik
AU  - HS Thomsen
AU  - M Østergaard
PY  - 2021
JO  - Scandinavian Journal of Rheumatology
DO  - 10.1080/03009742.2021.1935312
UR  - https://doi.org/10.1080/03009742.2021.1935312
ER  -

APA

Møller-Bisgaard, S., Hørslev-Petersen, K., Ejbjerg, B., Hetland, M., Christensen, R., Ørnbjerg, L., Glinatsi, D., Møller, J., Boesen, M., Stengaard-Pedersen, K., Madsen, O., Jensen, B., Villadsen, J., Hauge, E., Bennett, P., Hendricks, O., Asmussen, K., Kowalski, M., Lindegaard, H., Bliddal, H., Krogh, N., Ellingsen, T., Nielsen, A., Larsen, L., Jurik, A., Thomsen, H., & Østergaard, M. (2021). Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial. Scandinavian Journal of Rheumatology. https://doi.org/10.1080/03009742.2021.1935312

Source records

crossref · retrieved 2026-09-26T09:45:44.360Z